vs
American Well Corp（AMWL）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是American Well Corp的1.4倍（$75.5M vs $55.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -22.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-17.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -3.6%）
美国烟草公司由J.B.杜克于1890年整合多家美国烟草制造商合并创立，1896年成为道琼斯工业平均指数最初的12支成分股之一。该公司收购了好彩公司及超过200家竞争对手，一度垄断美国烟草行业。1907年美国联邦政府发起反垄断诉讼，最终将该公司分拆为多家企业。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AMWL vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$55.3M
营收增速更快
PBYI
高出49.8%
-22.1%
自由现金流更多
PBYI
多$31.8M
$-17.4M
两年增速更快
PBYI
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.3M | $75.5M |
| 净利润 | $-24.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -45.5% | 22.7% |
| 净利率 | -45.1% | — |
| 营收同比 | -22.1% | 27.7% |
| 净利润同比 | 41.6% | — |
| 每股收益（稀释后） | $-1.53 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMWLPBYI
| Q4 25 | $55.3M | $75.5M | ||
| Q3 25 | $56.3M | $54.5M | ||
| Q2 25 | $70.9M | $52.4M | ||
| Q1 25 | $66.8M | $46.0M | ||
| Q4 24 | $71.0M | $59.1M | ||
| Q3 24 | $61.0M | $80.5M | ||
| Q2 24 | $62.8M | $47.1M | ||
| Q1 24 | $59.5M | $43.8M |
净利润AMWLPBYI
| Q4 25 | $-24.9M | — | ||
| Q3 25 | $-32.4M | $8.8M | ||
| Q2 25 | $-19.7M | $5.9M | ||
| Q1 25 | $-18.7M | $3.0M | ||
| Q4 24 | $-42.7M | — | ||
| Q3 24 | $-43.5M | $20.3M | ||
| Q2 24 | $-49.9M | $-4.5M | ||
| Q1 24 | $-72.1M | $-4.8M |
毛利率AMWLPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率AMWLPBYI
| Q4 25 | -45.5% | 22.7% | ||
| Q3 25 | -52.1% | 17.6% | ||
| Q2 25 | -28.7% | 12.7% | ||
| Q1 25 | -45.5% | 8.7% | ||
| Q4 24 | -60.2% | 22.6% | ||
| Q3 24 | -77.6% | 27.4% | ||
| Q2 24 | -83.4% | -4.6% | ||
| Q1 24 | -126.1% | -5.3% |
净利率AMWLPBYI
| Q4 25 | -45.1% | — | ||
| Q3 25 | -57.5% | 16.2% | ||
| Q2 25 | -27.8% | 11.2% | ||
| Q1 25 | -28.0% | 6.5% | ||
| Q4 24 | -60.1% | — | ||
| Q3 24 | -71.2% | 25.2% | ||
| Q2 24 | -79.5% | -9.6% | ||
| Q1 24 | -121.1% | -11.0% |
每股收益（稀释后）AMWLPBYI
| Q4 25 | $-1.53 | $0.26 | ||
| Q3 25 | $-2.00 | $0.17 | ||
| Q2 25 | $-1.24 | $0.12 | ||
| Q1 25 | $-1.19 | $0.06 | ||
| Q4 24 | $-2.71 | $0.40 | ||
| Q3 24 | $-2.87 | $0.41 | ||
| Q2 24 | $-3.36 | $-0.09 | ||
| Q1 24 | $-4.94 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $182.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $235.6M | $130.3M |
| 总资产 | $323.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AMWLPBYI
| Q4 25 | $182.3M | $97.5M | ||
| Q3 25 | $200.9M | $94.4M | ||
| Q2 25 | $219.1M | $96.0M | ||
| Q1 25 | $222.4M | $93.2M | ||
| Q4 24 | $228.3M | $101.0M | ||
| Q3 24 | $244.6M | $96.7M | ||
| Q2 24 | $276.9M | $96.8M | ||
| Q1 24 | $308.6M | $107.2M |
总债务AMWLPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益AMWLPBYI
| Q4 25 | $235.6M | $130.3M | ||
| Q3 25 | $254.9M | $115.3M | ||
| Q2 25 | $282.6M | $104.7M | ||
| Q1 25 | $294.0M | $97.1M | ||
| Q4 24 | $304.8M | $92.1M | ||
| Q3 24 | $336.7M | $71.1M | ||
| Q2 24 | $363.9M | $48.5M | ||
| Q1 24 | $408.7M | $51.0M |
总资产AMWLPBYI
| Q4 25 | $323.8M | $216.3M | ||
| Q3 25 | $359.4M | $202.9M | ||
| Q2 25 | $388.7M | $194.9M | ||
| Q1 25 | $419.5M | $196.2M | ||
| Q4 24 | $436.0M | $213.3M | ||
| Q3 24 | $483.0M | $220.7M | ||
| Q2 24 | $507.8M | $205.0M | ||
| Q1 24 | $548.4M | $214.1M |
负债/权益比AMWLPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | $14.4M |
| 自由现金流率自由现金流/营收 | -31.4% | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流AMWLPBYI
| Q4 25 | $-17.4M | $14.4M | ||
| Q3 25 | $-18.8M | $9.7M | ||
| Q2 25 | $-4.7M | $14.1M | ||
| Q1 25 | $-25.1M | $3.6M | ||
| Q4 24 | $-13.4M | $15.6M | ||
| Q3 24 | $-32.4M | $11.0M | ||
| Q2 24 | $-21.8M | $1.0M | ||
| Q1 24 | $-59.8M | $11.2M |
自由现金流AMWLPBYI
| Q4 25 | $-17.4M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $-25.1M | $3.6M | ||
| Q4 24 | $-13.4M | $15.6M | ||
| Q3 24 | $-32.4M | $11.0M | ||
| Q2 24 | $-21.8M | $1.0M | ||
| Q1 24 | $-59.8M | — |
自由现金流率AMWLPBYI
| Q4 25 | -31.4% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | -37.6% | 7.7% | ||
| Q4 24 | -18.9% | 26.4% | ||
| Q3 24 | -53.0% | 13.7% | ||
| Q2 24 | -34.7% | 2.1% | ||
| Q1 24 | -100.5% | — |
资本支出强度AMWLPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率AMWLPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMWL
| Platform Subscription | $28.8M | 52% |
| Visits | $23.7M | 43% |
| Others | $2.8M | 5% |
PBYI
暂无分部数据
